Ginfast FRT is a clinically balanced formulation designed to support female fertility, ovulation, and hormonal balance.
It combines nutraceutical and adaptogenic ingredients to address multiple causes of infertility, both metabolic and hormonal.
| Ingredient | Pharmacological Properties | |
|---|---|---|
| Myo-Inositol | Enhances insulin sensitivity, restores ovulation, improves oocyte quality, and reduces ovarian androgen production in PCOS. | |
| Ashwagandha KSM-66® (Withania somnifera) | Adaptogenic; lowers cortisol, restores hypothalamic–pituitary–ovarian (HPO) axis balance, reduces stress-induced anovulation, and improves libido and mood. | |
| Vitex agnus-castus (Chaste Tree Extract) | Dopaminergic activity lowers prolactin, normalizes LH/FSH ratio, supports luteal phase, and improves menstrual regularity. | |
| Coenzyme Q10 | Mitochondrial energizer; enhances ATP production in oocytes, improves egg quality, delays ovarian aging, and boosts IVF outcomes. | |
| Quatrefolic® (5-MTHF) | Active folate form; supports DNA synthesis, methylation, oocyte and embryo quality, and enhances endometrial receptivity. | |
| Selenium | Antioxidant; protects ovarian tissue from oxidative stress, supports thyroid function, and improves folliculogenesis. | |
| Vitamin D3 | Regulates AMH and FSH sensitivity, supports implantation, enhances endometrial receptivity, and reduces inflammation. |
Ginfast FRT is indicated for female infertility associated with:
1- Polycystic Ovary Syndrome (PCOS) and anovulatory cycles
2- Luteal phase defects and hyperprolactinemia
3- Endometrial receptivity impairment
4- Age-related infertility and poor oocyte quality
5- Oxidative stress and thyroid-related infertility
6- Infertility linked to folate or vitamin D deficiency
7- Stress-induced or idiopathic infertility
1- Enhances oocyte quality and mitochondrial energy production
2- Improves ovulation and menstrual regularity
3- Supports implantation and luteal function
4- Reduces oxidative and hormonal stress
5- Improves IVF and pregnancy outcomes


